List your company

Counterfactual Explanations on diabetes

49.8ValidityGS
-0.22412.76325.7538.737Feb 24, 2025

Evaluation results

MethodLinks
GSensemble=DARE2025.0249.82.24397.30.33768.6——
GSensemble=adversarial2025.0249.72.14997.10.42170——
GS2025.0249.52.10797.30.40167.4——
FACEensemble=adversarial2025.0244.52.22194.2069.60.647—
FACEensemble=DARE2025.0243.62.16192.40690.699—
FACE2025.02412.27993.4068.30.72—
DICEensemble=DARE2025.0240.72.47192.10.726710.583—
uncertainty+densemble=DARE2025.0240.42.1798.40.06666.40.674—
DICEensemble=adversarial2025.0238.32.66592.30.81971.70.695—
uncertainty+densemble=adversarial2025.0238.22.7761000.21874.50.84—
DICE2025.0237.92.61992.80.78271.90.662—
uncertainty+d2025.0235.72.5061000.25475.60.818—
uncertaintyensemble=adversarial2025.025.612.34798.510.25177.15.644—
uncertaintyensemble=DARE2025.022.56.39798.54.54276.52.346—
uncertainty2025.021.74.52598.52.60575.81.244—
BayConNon-actionable feature constraint=true, Selection strategy=Random2026.05——————3.3
BayConNon-actionable feature constraint=true, Selection strategy=Closest2026.05——————1.8
DiCENon-actionable feature constraint=true, Model access=Surrogate2026.05——————4
ExDBSCANNon-actionable feature constraint=true2026.05——————2.9
ExDBSCANNon-actionable feature constraint=true, Selection strategy=Random2026.05——————3.7
GSNon-actionable feature constraint=true, Model access=Surrogate2026.05——————2.9